Carb-X Funds Techulon’s Rapidly Adaptable Nano Therapeutic in Fight Against Drug Resistant Bacteria
CARB-X is awarding Techulon Inc., located in the Virginia Tech Corporate Research Center in Blacksburg, VA, USA, up to $785,000 ...
Florida’s Hepatitis A Outbreak Nears 3,000 Cases, Prompting Door-to-Door Vaccination Campaign
The Tampa Bay area has been hit especially hard by hepatitis A cases this year. The region has led the ...
Diagnosing Sepsis in Minutes: Cytovale Raises $15 Million in Financing
The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS) Office ...
H.R. 4374 – The Engineering Biology Research & Development Act of 2019
The Congressional Budget Office (CBO) issued a cost estimate report on Nov. 1 for The Engineering Biology Research and Development ...
Tracing the Ancestral Genome of The Plague
An international team of researchers has analyzed remains from ten archaeological sites in England, France, Germany, Russia, and Switzerland to ...
Debiopharm Progresses in Their Stand Against Drug-Resistant N. gonorrhoeae
Debiopharm, a Swiss biopharmaceutical company, announced today it has been awarded 2nd phase funding from the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator ...
Atriva Therapeutics Reports Results of Phase I Clinical Trial for ATR-002 Antiviral
Atriva Therapeutics GmbH has announced the successful conclusion and top-line results of its Phase I clinical trial for its lead ...
A ‘Shocking’ New Way To Treat Infections
Titanium has many properties that make it a great choice for use in implants. Its low density, high stiffness, high ...
Early Diagnostic Imaging of Sulfur Mustard Poisoning
Sulfur mustard is one of the most harmful chemical warfare agents and can induce skin, eye, and lung injuries. Detecting ...
WMD Nonproliferation: A Long-Standing Partnership to Secure “The Polygon”
The Semipalatinsk Test Site dates back to the origin of the Soviet Union’s nuclear program. Established in 1947 and referred ...
Aalto Bio Reagents Launches Protein for Detection of Venezuela Equine Encephalitis Virus
Aalto Bio Reagents Ltd. signed their first distribution agreement with a Japanese partner, Veritas Corporation, on Oct. 15, 2019. This ...
Biodefense Headlines – 21 October 2019
A selection of news and research updates from the team at Global Biodefense. POLICY + POLITICS UN Investigates Alleged Use ...
Highly Diluted Dose of Ebola Vaccine Shown Effective in Primate Study
A single dose of VSV-Ebola virus vaccine—approximately one-millionth of what is in the vaccine being used in the outbreak outbreak ...
Disease Diagnostic System Patent Application: Lab-On-A-Device
Researchers from the Charles R. Drew University of Medicine and Science have filed a patent application for a new diagnostic ...
USAMRIID Study Leads to Approval of New Smallpox Vaccine
A new vaccine approved in the U.S. on Sept. 24 prevents both smallpox and the related disease monkeypox in adults. ...
Upcoming Events
-
CBD S&T Conference 2019 – Chemical and Biological Defense
November 18 - November 21
